Compare NEU & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEU | MMSI |
|---|---|---|
| Founded | 1887 | 1987 |
| Country | United States | United States |
| Employees | 2060 | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 4.9B |
| IPO Year | N/A | 1990 |
| Metric | NEU | MMSI |
|---|---|---|
| Price | $595.15 | $81.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $106.22 |
| AVG Volume (30 Days) | 154.1K | ★ 591.9K |
| Earning Date | 02-11-2026 | 02-24-2026 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 44.44 | 1.95 |
| Revenue | ★ $2,725,169,000.00 | $1,477,128,000.00 |
| Revenue This Year | N/A | $13.67 |
| Revenue Next Year | N/A | $6.16 |
| P/E Ratio | ★ $13.34 | $41.85 |
| Revenue Growth | N/A | ★ 11.41 |
| 52 Week Low | $510.07 | $77.62 |
| 52 Week High | $875.97 | $110.10 |
| Indicator | NEU | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 28.49 | 48.25 |
| Support Level | $711.67 | $77.62 |
| Resistance Level | $734.52 | $82.28 |
| Average True Range (ATR) | 24.49 | 2.27 |
| MACD | -5.95 | 0.17 |
| Stochastic Oscillator | 1.77 | 76.23 |
NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives used in lubricating oils and fuels to enhance performance. The company operates through two segments: petroleum additives, mainly represented by Afton, where lubricant additives improve the efficiency and durability of base fluids and fuel additives help meet fuel specifications and improve fuel performance, and specialty materials, represented by AMPAC and Calca, including the antiknock compounds business of Ethyl, where primary raw materials include electricity, sodium chlorate, ammonia, chlorine, caustic, and hydrochloric acid, with graphite used in electrolytic cells. The company has operations in North America, Latin America, Asia Pacific, and EMEAI regions.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.